Verity & Verity’s VanEck Pharmaceutical ETF PPH Stock Holding History

Verity & Verity’s Portfolio PPH Stock Details PPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-131,320	Closed	-$11.6M	–	138
2025 Q2	$11.6M	Buy	+131,320	New	+$11.4M	0.99%	48
2024 Q1	–	Sell	-95,555	Closed	-$7.77M	–	119
2023 Q4	$7.77M	Buy	+95,555	New	+$7.49M	0.89%	48

Other funds holding PPH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

JSAM

J. Safra Asset Management New York $1.86B AUM 22.95% 1-Year Est. Return

Avalon Trust Santa Fe, New Mexico $1.45B AUM 35.31% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

MIM

Miller Investment Management West Conshohocken, Pennsylvania $1.01B AUM 13.96% 1-Year Est. Return

Verity & Verity's PPH Position: Q3 2025 in Review

Verity & Verity sold out of VanEck Pharmaceutical ETF (PPH) in Q3 2025, closing a stake of 131,320 shares — an estimated $11.6M sold.

Verity & Verity first reported a position in PPH in Q4 2023 and held it in 2 quarters. The position peaked at $11.6M in Q2 2025. 127 funds tracked by Wall St. Rank hold PPH as of Q3 2025.

Verity & Verity reported no remaining VanEck Pharmaceutical ETF position as of Q3 2025 after selling out during the quarter.
Verity & Verity sold 131,320 VanEck Pharmaceutical ETF shares in Q3 2025, an estimated $11.6M.
Verity & Verity first reported a position in VanEck Pharmaceutical ETF in Q4 2023 and held it in 2 quarters.
Verity & Verity's VanEck Pharmaceutical ETF position peaked at $11.6M in Q2 2025.
127 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q3 2025.

Based on Verity & Verity's 13F filing for Q3 2025, filed 21 Oct 2025.